In a major scientific breakthrough, scientists in the United Kingdom have successfully tested a new form of gene therapy, ‘Base Editing’, for the first time in a patient with T-cell Acute Lymphoblastic Leukemia (T-ALL), a type of blood cancer.
T-cells
|